Home > National Drug Code (NDC) > Carbidopa and Levodopa

Carbidopa and Levodopa - 60505-0131-1 - (Carbidopa and Levodopa)

Alphabetical Index


Drug Information of Carbidopa and Levodopa

Product NDC: 60505-0131
Proprietary Name: Carbidopa and Levodopa
Non Proprietary Name: Carbidopa and Levodopa
Active Ingredient(s): 25; 100    mg/1; mg/1 & nbsp;   Carbidopa and Levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and Levodopa

Product NDC: 60505-0131
Labeler Name: Apotex Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076212
Marketing Category: ANDA
Start Marketing Date: 20040616

Package Information of Carbidopa and Levodopa

Package NDC: 60505-0131-1
Package Description: 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0131-1)

NDC Information of Carbidopa and Levodopa

NDC Code 60505-0131-1
Proprietary Name Carbidopa and Levodopa
Package Description 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-0131-1)
Product NDC 60505-0131
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carbidopa and Levodopa
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20040616
Marketing Category Name ANDA
Labeler Name Apotex Corp.
Substance Name CARBIDOPA; LEVODOPA
Strength Number 25; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and Levodopa


General Information